| Old Articles: <Older 44431-44440 Newer> |
|---|
 |
The Motley Fool
September 30, 2010
John Rosevear |
Ford's Deceptively Simple Strategy Why "One Ford" is about to bear fruit in a big way.   |
The Motley Fool
September 30, 2010
Matt Koppenheffer |
Big Banks Abandon Proprietary Trading Why would banks abandon a way to make money? |
The Motley Fool
September 30, 2010
Brian Orelli |
Chief Justice Roberts Sold Pfizer. Should You? Maybe, but not for the same reason. |
The Motley Fool
September 30, 2010
Sophia Meng |
Apple's AirPlay Could Be a Big Hit Apple's newest iProduct has great potential. |
The Motley Fool
September 30, 2010
Rich Smith |
You've Got to Be Kidding, Boeing Another day. Another Boeing delay. |
The Motley Fool
September 30, 2010
Seth Jayson |
From Gross to Net at Alliance Data Systems Here's the current margin snapshot for Alliance Data Systems and some of its sector and industry peers and direct competitors. |
The Motley Fool
September 30, 2010
Anders Bylund |
Black Clouds Over Green Mountain If you can't trust the revenue line, how can you make an investment decision? |
The Motley Fool
September 30, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Another analyst calls it quits on Altria. |
The Motley Fool
September 30, 2010
Seth Jayson |
Where Is United Technologies' Bottom Line Headed? Here's the current margin snapshot for United Technologies and some of its sector and industry peers and direct competitors. |
The Motley Fool
September 30, 2010
Brian Orelli |
Avoid This Multibillion-Dollar Market It's just too crowded, but there's no doubt that psychiatric drugs are big business for some drugmakers. |
| <Older 44431-44440 Newer> Return to current articles. |
